期刊文献+

精氨酸多肽-抗生素偶联物对细菌性膀胱炎家兔动物模型治疗的研究

Therapeutic effect of antibiotic conjugated with 11 poly-arginine peptide on rabbit model with bacterial cystitis
下载PDF
导出
摘要 目的:探讨精氨酸多肽-环丙沙星偶联物(R11-Cipro)对细菌性膀胱炎家兔模型的治疗作用。方法:选取4月龄新西兰家兔50只,成功建立细菌性膀胱炎动物模型后,随机分为5组。A组为空白对照组、B组为膀胱灌注R11组、C组为膀胱灌注Cipro组、D组为膀胱灌注Cipro-R11组、E组为经耳缘静脉注射Cipro组。观察排尿频率、尿液细菌培养以及获取膀胱组织,HE染色,观察其病理变化。结果:建模后膀胱黏膜上皮出现严重的炎症改变和炎症细胞浸润,R11-Cipro组治疗后膀胱炎症改善最明显,甚至优于经静脉Cipro组(P<0.05);在排尿频率及尿细菌培养方面,R11-Cipro组亦显著优于其余四组。结论:R11-Cipro经膀胱灌注对家兔细菌性膀胱炎具有显著的治疗效果,R11这个高效载体能有效运载抗生素到膀胱内发挥良好的靶向杀菌活性。 Objective To investigate the therapeutic effect of ciprofloxacin (Cipro) conjugated with 11poly-arginine peptide (Rll) on rabbit model with bacterial cystitis (BC). Methods 50 New Zealand rabbits of4-month old were chosen to establish the models and evenly divided into 5 groups randomly Group A: normalcontrol; Group B: intravesical instillation (II) of Rll; Group C: II of Cipro; Group D: II of Rll-Cipro; GroupE: intravenous injection of Cipro. Several parameters were observed which included: urinary frequency, positiverate of urine culture, histopathological analysis of cystitis stained with hematoxylin and eosin. Results Severeinflammatory responses and massive infiltration of inflammatory cells were observed after the models wereestablished. Rll-Cipro group was better than intravenous injection of Cipro group in treating cystitis (P 〈 0.05).Ri 1-Cipro group was better than the other four groups in urinary frequency and urine culture. ConclusionsIntravesical instillation of R11-Cipro demonstrated significant therapeutic effect on bacterial cystitis. R11, as anefficient vector, could deliver specific antibiotics to bladder mucosa precisely and function well locally.
出处 《实用医学杂志》 CAS 北大核心 2014年第18期2883-2886,共4页 The Journal of Practical Medicine
基金 广东省科技计划项目(编号:2012B031800324)
关键词 精氨酸多肽 载体 抗生素 细菌性膀胱炎 膀胱灌注 Poly-arginine peptide Vector Antibiotic Bacterial cystitis Intravesical instillation
  • 相关文献

参考文献13

  • 1任建丽,王志刚,张勇,李兴升,汪朝霞,张群霞,许川山.穿膜肽TAT的固相合成及体外活性研究[J].第三军医大学学报,2008,30(7):659-661. 被引量:3
  • 2沈红,王珍.儿童泌尿系感染病原菌分布及耐药性分析[J].实用医学杂志,2011,27(13):2447-2448. 被引量:9
  • 3廖慧华,蔡德鸿.糖尿病和非糖尿病患者尿路感染的临床分析[J].实用医学杂志,2011,27(11):1995-1997. 被引量:28
  • 4Ronald A. The etiology of urinary tract infection: traditional and emergi ng Pathogens [J]. Am J Med, 2002, 113 (Suppl 1A):14S-19S.
  • 5Buyse G, Waldeck K, Verpoorten C, et al. Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism [J]. J Urol, 1998,160(3 Pt 1): 892-896.
  • 6Di Stasi SM, Giannantoni A, Stephen RL, et al. Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: a prospective randomized study[J]. J Urol, 2003,170(3):777-782.
  • 7Schwarze SR, Ho A, Vocero-Akbani A, et al. In vivo protein transduction: delivery of a biologically active protein into the mouse[J]. Science, 1999,285(5433): 1569-1572.
  • 8Mae M, Langel U. Cell- penetrating peptides as vectors for peptide, protein and oligonucleotide delivery [J]. CUIT Opin Pharmacol,2006,6(5):509-514.
  • 9El- Andaloussi S, Holm T, Langel U. Cellpenetrating peptides , mechanisms and applications [J]. CUIT Pharm Des, 2005, 11 (28) :3597-3611.
  • 10Deshayes S, Morris MC, Divita G, et al. Cell-penetrating peptides- tools for intracellular delivery of therapeutics [J] . Cell Mol Life Sci, 2005,62(16): 1839-1849.

二级参考文献19

  • 1吴金英,李岩斌,王士忠,苏兆兰.大肠埃希菌感染的临床分布与耐药性[J].中华医院感染学杂志,2004,14(7):826-827. 被引量:30
  • 2何卓雄.糖尿病尿路感染菌群分布及药敏情况[J].国际医药卫生导报,2007,13(2):92-93. 被引量:5
  • 3Zorc J J, Kiddoo D A, Shaw K N. Diagnosis and management of pediatric urinary tract infections [J]. Clin Microbiol Rev, 2005,18(2) :417-422.
  • 4Zhang Y M, Liu C B, Liu N, et al. Electrostatic binding with tat and other cationic peptides increases cell accumulation of 99mTc-antisense DNAs without entrapment[ J]. Mol Imaging Biol, 2003, 5 (4) : 240 - 247.
  • 5Nitin N, LaConte L E, Zurkiya O, et al. Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent[J]. J Biol Inorg Chem, 2004, 9(6) : 706 -712.
  • 6Hu M, Chen P, Wang J, et al. ^123I-labeled HIV-1 tat peptide radioimmunoconjugates are imported into the nucleus of breast cancer cells and functionally interact in vitro and in vivo with the cyclin-dependent kinase inhibitor, p21^WAF-1/Cip-1 [ J]. Eur J Nucl Med Mol Imaging, 2007, 34(3) : 368 -377.
  • 7Rudolph C, Plank C, Lausier J, et al. Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells[J]. J Biol Chem, 2003, 278(13) : 11411 -11418.
  • 8Ignatovich I A, Dizhe E B, Pavlotskaya A V, et al. Complexes of plasmid DNA with basic domain 47 - 57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways[ J]. J Biol Chem, 2003, 278 (43) : 42625 - 42636.
  • 9奥斯伯FM,布伦特R,金斯顿RE.精编分子生物学实验指南[M].颜子颖,王海林,译.北京:科学出版社,2001:388-389.
  • 10Liu Z, Li M, Cui D, et al. Macro-branched cell-penetrating peptide design for gene delivery[J]. J Control Release, 2005, 102(3) : 699 -710.

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部